Skip to main content

Table 1 Baseline characteristics of the Norwegian female population* in 1996 by pregnancy status, age, history of Pap smear and invitation to the cervical cancer screening programme

From: Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study

 

Pregnancy status

 

Reference cohort 2 060 118 (%)

Pregnant cohort 24 297 (%)

Mixed cohort 91 347 (%)

Age-groups

   

< 14

445 928 (21.7)

18 (0.07)

11 (0.01)

15–19

125 039 (6.1)

1688 (7.0)

4090 (4.5)

20–24

130 147 (6.3)

6087 (25.0)

20 103 (22.1)

25–29

127 742 (6.1)

9112 (37.5)

34 809 (38.1)

30–34

131 081 (6.4)

5555 (22.9)

23 530 (25.8)

35–39

144 959 (7.0)

1653 (6.8)

7756 (8.5)

40–44

146 978 (7.1)

178 (0.7)

1024 (1.1)

45–49

149 296 (7.2)

6 (0.02)

24 (0.03)

50–69

394 224 (19.1)

-

-

70+

267 724 (13.0)

-

-

Time since last Pap smear before T0

   

0–12 months

441 735 (21.4)

9342 (38.4)

36 318 (39.8)

13–24 months

278 490 (13.5)

5934 (24.4)

23 304 (25.5)

25–36 months

181 158 (8.8)

3662 (15.1)

13 113 (14.4)

> 36 months

1 158 735 (56.2)

5359 (22.1)

18 612 (20.4)

Time since invitation

   

No invitation

1 567 788 (76.1)

18 374 (75.6)

75 393 (82.5)

24–2 months prior to T0

229 417 (11.1)

2596 (10.7)

989 (1.1)

1 months prior-3 months after T0

132 981 (6.5)

2256 (9.3)

3524 (3.9)

> 3 months after T0

129 932 (6.3)

1071 (4.4)

11 441 (12.5)

  1. * 39 707 were excluded because they were either born before 1900, diagnosed with invasive cervical cancer and/or underwent hysterectomy before 1996, died in 1997 or had inadequate data for estimating duration of the pregnancy